I
Ioannis P. Androulakis
Researcher at Rutgers University
Publications - 208
Citations - 6555
Ioannis P. Androulakis is an academic researcher from Rutgers University. The author has contributed to research in topics: Circadian rhythm & Gene expression profiling. The author has an hindex of 38, co-authored 202 publications receiving 5862 citations. Previous affiliations of Ioannis P. Androulakis include National Technical University & Princeton University.
Papers
More filters
Journal ArticleDOI
αBB: A global optimization method for general constrained nonconvex problems
TL;DR: The proposed branch and bound type algorithm attains finiteε-convergence to the global minimum through the successive subdivision of the original region and the subsequent solution of a series of nonlinear convex minimization problems.
Journal ArticleDOI
A global optimization method, αBB, for general twice-differentiable constrained NLPs—II. Implementation and computational results
TL;DR: The performance of the proposed algorithm and its alternative underestimators is studied through their application to a variety of problems and a number of rules for branching variable selection and variable bound updates are shown to enhance convergence rates.
Journal ArticleDOI
Cytoskeleton-based forecasting of stem cell lineage fates
Matthew D. Treiser,Eric Yang,Simon Gordonov,Daniel M. Cohen,Ioannis P. Androulakis,Joachim Kohn,Christopher S. Chen,Prabhas V. Moghe +7 more
TL;DR: This study reports that higher-order variations in cell shape and cytoskeletal organization that occur within hours of stimulation forecast the lineage commitment fates of human mesenchymal stem cells (hMSCs).
Journal ArticleDOI
Global optimization of mixed‐integer nonlinear problems
TL;DR: Two novel deterministic global optimization algorithms for nonconvex mixed-integer problems (MINLPs) are proposed, using the advances of the αBB algorithm for non Convex NLPs of Adjiman et al.
Journal ArticleDOI
The growing role of precision and personalized medicine for cancer treatment
Paulina Krzyszczyk,Alison Acevedo,Erika J Davidoff,Lauren M Timmins,Ileana Marrero-Berrios,Misaal Patel,Corina White,Christopher J. Lowe,Joseph J. Sherba,Clara Hartmanshenn,Kate O'Neill,Max L. Balter,Zachary Fritz,Ioannis P. Androulakis,Rene S. Schloss,Martin L. Yarmush +15 more
TL;DR: It is clear that PPM cancer treatments can result in immense patient benefits, and companies and regulatory agencies have begun to recognize this, but broader changes to the healthcare and insurance systems must be addressed if PPM is to become part of standard cancer care.